e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Biomarkers and assessment of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased levels of circulating endothelial progenitor cells during exacerbations of COPD
E. Sala, C. Villena, C. Fernandez-Palomeque, A. Rios, H. Martinez, B. Garcia-Cosio, J. Vidal, J. Garcia, B. Nunez, A. Agusti (Mallorca, Spain)
Source:
Annual Congress 2007 - Biomarkers and assessment of COPD
Session:
Biomarkers and assessment of COPD
Session type:
Oral Presentation
Number:
415
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Sala, C. Villena, C. Fernandez-Palomeque, A. Rios, H. Martinez, B. Garcia-Cosio, J. Vidal, J. Garcia, B. Nunez, A. Agusti (Mallorca, Spain). Increased levels of circulating endothelial progenitor cells during exacerbations of COPD. Eur Respir J 2007; 30: Suppl. 51, 415
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Decreased number of circulating endothelial progenitor cells in patients with emphysema
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005
Effects of training on endothelial function and circulating endothelial progenitor cells in COPD patients
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Circulating haemopoietic and endothelial progenitor cells are decreased in COPD
Source: Eur Respir J 2006; 27: 529-541
Year: 2006
Distinct patterns of circulating endothelial cells in pulmonary hypertension
Source: Eur Respir J 2010; 36: 1284-1293
Year: 2010
Circulating endothelial progenitor cells and CD45+ cells in pulmonary arteries of COPD patients
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Inhaled corticosteroids reduce senescence in endothelial progenitor cells from COPD patients
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
Endothelial progenitor cells (EPC) in patients with chronic bronchitis or COPD
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Circulating progenitor cells in COPD patients
Source: Annual Congress 2011 - Bone marrow-derived stem cells in respiratory diseases: a future therapy?
Year: 2011
Increased circulating endothelial microparticles in COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Late endothelial progenitor cells are senescent and dysfunctional in COPD due to reduced sirtuin-1 levels
Source: Annual Congress 2011 - Novel mechanisms in COPD
Year: 2011
Post-COVID-19 patients show an increased endothelial progenitor cell production
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021
Treatment of COPD exacerbations is able to influence the mononuclear cells level of the peripheral blood
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Circulating mature and progenitor eosinophils in patients with stable asthma express all major traffic related receptors
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012
Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 1s
Year: 2002
Increase in sputum levels of vascular endothelial progenitor cells in asthmatic subjects following allergen inhalation challenge
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
Decreased circulating endothelial progenitor cells in obstructive sleep apnea
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Circulating fibrocytes are increased in children and young adults with pulmonary hypertension
Source: Eur Respir J 2012; 39: 104-111
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept